Alerts will be sent to your verified email
Verify Email
EVERESTO
|
Everest Organics
|
Haleos Labs
|
Nectar Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.73 % | 9.57 % | -0.71 % |
|
5yr Avg Net Profit Margin
|
2.92 % | 4.57 % | -0.63 % |
|
Price to Book
|
5.38 | 1.77 | 0.33 |
|
P/E
|
60.59 | 20.08 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-87.83 Days | -0.85 Days | 81.28 Days |
|
5yr Average Interest Coverage Ratio
|
3.02 | 4.15 | 0.94 |
|
5yr Avg ROCE
|
19.01 % | 10.58 % | 7.51 % |
|
5yr Avg Operating Profit Margin
|
6.68 % | 10.06 % | 7.57 % |
|
5 yr average Debt to Equity
|
0.84 | 0.54 | 0.73 |
|
5yr CAGR Net Profit
|
-58.15 % | -2.24 % | -31.15 % |
|
5yr Average Return on Assets
|
3.96 % | 4.11 % | -0.34 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
60.78 % | 71.41 % | 44.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 99.6 % |
|
Change in Promoter Holding (3 Yrs)
|
-13.37 % | 1.56 % | -11.27 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Everest Organics
|
Haleos Labs
|
Nectar Lifesciences
|
|---|